{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:34:19Z","timestamp":1764995659163,"version":"3.46.0"},"reference-count":35,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Gorham disease is a rare pathological condition characterised by a proliferation of vascular channels of haematic and lymphatic origin in bone and adjacent soft tissues, which results in a progressive destruction of the involved bone segment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To evaluate expression of the vascular endothelial cell marker CD105\/endoglin in Gorham disease of bone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An immunohistochemical analysis was conducted on four cases of Gorham disease of bone, and for comparison on eight cases of conventional haemangioma of bone and on normal fetal and adult bone tissue specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Diffuse and intense immunostaining of endothelial cells for CD105 was observed in the specimens of fetal bone in areas undergoing ossification and in the growth plate of young adults. In medullary bone, CD105 positivity was limited to sinusoids of haemopoietic marrow, while endothelial cells of capillaries and small arterioles and venules within fatty marrow were either negative or showed weak immunostaining. The mean percentage of positive vessels in Gorham disease was significantly higher than in osseous haemangioma (58.9 (SEM 14.9) vs 17.2 (SEM 12.0); p\u200a=\u200a0.03, Mann\u2013Whitney U test). A significant direct correlation was observed between the proliferative activity assessed by MIB-1 immunostaining, and the percentage of CD105 positive vessels in the entire series (r\u200a=\u200a0.681; p\u200a=\u200a0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Data indicate that the phenotype of proliferating endothelial cells of Gorham disease is similar to that of the endothelial lining of vessels of metabolically active bone characterised by high expression of CD105, while that of conventional haemangioma is more similar to that of metabolically quiescent bone tissue, such as fatty marrow, with low levels of expression of CD105. This may have potential therapeutic and diagnostic applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jcp.2008.060160","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T21:39:59Z","timestamp":1233265199000},"page":"163-167","source":"Crossref","is-referenced-by-count":23,"title":["CD105\/endoglin expression in Gorham disease of bone"],"prefix":"10.1136","volume":"62","author":[{"given":"A","family":"Franchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bacchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Mourmouras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Miracco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"2025120519592225000_62.2.163.1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9343(54)90027-3","article-title":"Disappearing bones: a rare form of massive osteolysis: report of two cases, one with autopsy findings.","volume":"17","author":"Gorham","year":"1954","journal-title":"Am J Med"},{"key":"2025120519592225000_62.2.163.2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2106\/00004623-195537050-00008","article-title":"Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone): its relation to hemangiomatosis.","volume":"37A","author":"Gorham","year":"1955","journal-title":"J Bone Joint Surg [Am]"},{"key":"2025120519592225000_62.2.163.3","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(90)90215-K"},{"key":"2025120519592225000_62.2.163.4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00003086-199309000-00038","article-title":"Massive osteolysis.","volume":"294","author":"Shives","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"2025120519592225000_62.2.163.5","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.81B3.9468"},{"key":"2025120519592225000_62.2.163.6","doi-asserted-by":"publisher","DOI":"10.1002\/path.989"},{"key":"2025120519592225000_62.2.163.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.5.1893"},{"key":"2025120519592225000_62.2.163.8","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1016\/S0021-9258(19)38892-1","article-title":"Primary structure of endoglin, an RGD containing glycoprotein of human endothelial cells.","volume":"265","author":"Gougos","year":"1990","journal-title":"J Biol Chem"},{"key":"2025120519592225000_62.2.163.9","first-page":"F105","article-title":"TGF-\u03b2 receptor signaling.","volume":"1333","author":"Derynck","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"2025120519592225000_62.2.163.10","first-page":"1623","article-title":"Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.","volume":"1","author":"Burrows","year":"1995","journal-title":"Clin Cancer Res"},{"key":"2025120519592225000_62.2.163.11","unstructured":"Letarte M Greaves A Vera S . CD105 (endoglin). In: Schlossman S F Baumsell L Gilks W , eds. Leukocyte typing. Oxford: Oxford University Press, 1995:1756\u20139."},{"key":"2025120519592225000_62.2.163.12","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.051019"},{"key":"2025120519592225000_62.2.163.13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011611200"},{"key":"2025120519592225000_62.2.163.14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1096\/fasebj.14.1.55","article-title":"CD105 antagonizes the inhibitory signaling of transforming growth factor \u03b21 on human vascular endothelial cells.","volume":"14","author":"Li","year":"2000","journal-title":"FASEB J"},{"key":"2025120519592225000_62.2.163.15","first-page":"2037","article-title":"Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model.","volume":"6","author":"Fonsatti","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2025120519592225000_62.2.163.16","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.0.CO;2-X"},{"key":"2025120519592225000_62.2.163.17","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5419.1534"},{"key":"2025120519592225000_62.2.163.18","doi-asserted-by":"publisher","DOI":"10.1038\/ng1294-345"},{"key":"2025120519592225000_62.2.163.19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.5.386"},{"key":"2025120519592225000_62.2.163.20","first-page":"1031","article-title":"Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.","volume":"3","author":"Seon","year":"1997","journal-title":"Clin Cancer Res"},{"key":"2025120519592225000_62.2.163.21","first-page":"3621","article-title":"Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.","volume":"18","author":"Bodey","year":"1998","journal-title":"Anticancer Res"},{"key":"2025120519592225000_62.2.163.22","first-page":"2701","article-title":"Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.","volume":"18","author":"Bodey","year":"1998","journal-title":"Anticancer Res"},{"key":"2025120519592225000_62.2.163.23","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.0.CO;2-X"},{"key":"2025120519592225000_62.2.163.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-006-0044-4"},{"key":"2025120519592225000_62.2.163.25","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041113"},{"key":"2025120519592225000_62.2.163.26","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0660"},{"key":"2025120519592225000_62.2.163.27","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199703000-00004"},{"key":"2025120519592225000_62.2.163.28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11551"},{"key":"2025120519592225000_62.2.163.29","first-page":"1031","article-title":"Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.","volume":"3","author":"Seon","year":"1997","journal-title":"Clin Cancer Res"},{"key":"2025120519592225000_62.2.163.30","first-page":"371","article-title":"Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.","volume":"5","author":"Matsuno","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2025120519592225000_62.2.163.31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<737::AID-IJC18>3.0.CO;2-8"},{"key":"2025120519592225000_62.2.163.32","first-page":"7846","article-title":"Antiangiogenic therapy of established tumors in human skin\/severe combined immunodeficiency mouse chimeras by anti-endoglin [CD105] monoclonal antibodies, and synergy between antiendoglin antibody and cyclophosphamide.","volume":"61","author":"Takahashi","year":"2001","journal-title":"Cancer Res"},{"key":"2025120519592225000_62.2.163.33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2962"},{"key":"2025120519592225000_62.2.163.34","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<122::AID-IJC4>3.0.CO;2-M"},{"key":"2025120519592225000_62.2.163.35","first-page":"524","article-title":"Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin.","volume":"7","author":"Takahashi","year":"2001","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.2008.060160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:59:31Z","timestamp":1764993571000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.2008.060160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,1,29]]},"published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1136\/jcp.2008.060160"],"URL":"https:\/\/doi.org\/10.1136\/jcp.2008.060160","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}